For decades, HIV has been the villain in humanity’s soap opera, showing up uninvited at parties, breaking hearts, and generally ruining the vibe. But now, science is pulling a full plot twist: a preventative drug priced at just $40 a year, set to roll out globally by 2027.

Forty bucks. That’s less than what many people accidentally spend on late-night takeout after two margaritas. For the price of one questionable concert ticket or a single pair of “emergency” sunglasses bought at an airport, people will have protection that could actually end HIV transmissions worldwide.

Doctors are calling it revolutionary. Activists are calling it overdue. And the rest of us? We’re calling it the best bargain since streaming services remembered to bundle.

By 2027, HIV might go the way of floppy disks, phone books, and frosted tips, something future generations hear about but never actually encounter.

The future looks safer, cheaper, and way sexier.